Author:
Okumus Özlem,Mardanzai Khaled,Plönes Till,Theegarten Dirk,Darwiche Kaid,Schuler Martin,Nensa Felix,Hautzel Hubertus,Hermann Ken,Stuschke Martin,Hegedus Balazs,Aigner Clemens
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference35 articles.
1. A. Kandathil, F. U. Kay, Y. M. Butt, J. W. Wachsmann, and R. M. Subramaniam, “Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non-Small Cell Lung Cancer,” Radiographics, vol. 38, no. 7, pp. 2134-2149, Nov-Dec 2018.
2. Prediction of occult lymph node metastasis using SUV, volumetric parameters and intratumoral heterogeneity of the primary tumor in T1–2N0M0 lung cancer patients staged by PET/CT;Ouyang;Ann Nucl Med,2019
3. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer;De Leyn;Eur J Cardiothorac Surg,2014
4. J. Vansteenkiste et al., “Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up,” Ann Oncol, vol. 24 Suppl 6, pp. vi89-98, Oct 2013.
5. G. Goeckenjan et al., “[Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version],” Pneumologie, vol. 65, no. 8, pp. e51-75, Aug 2011. Pravention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. Interdisziplinare S3-Leitlinie der Deutschen Gesellschaft fur Pneumologie und Beatmungsmedizin und der Deutschen Krebsgesellschaft--Kurzfassung.